TMO
Thermo Fisher Scientific Inc
662.10$
+0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 23.8% | 24.9% | 24.3% | 25.9% | 23.7% | 22.7% | 23.6% | 24.3% | 21.6% | 26.0% | 19.7% | 20.6% | |
| 6.3% | 8.2% | 5.7% | 7.2% | 4.6% | 4.1% | 4.2% | 4.5% | 1.9% | 8.9% | 2.9% | 3.6% | |
| 6.3% | 8.2% | 7.5% | 9.0% | 6.6% | 5.7% | 6.0% | 6.3% | 3.4% | 9.2% | 2.9% | 3.6% | |
| 10.1% | 9.8% | 9.6% | 9.6% | 9.8% | 9.9% | 9.9% | 9.9% | 10.2% | 9.6% | 9.6% | 8.4% | |
| 5.6% | 5.2% | 5.3% | 5.3% | 5.4% | 5.1% | 5.3% | 5.5% | 5.6% | 4.9% | 4.9% | 5.0% | |
| 9.4% | – | – | – | 9.4% | 9.6% | 9.4% | 9.5% | 9.9% | 9.6% | – | – | |
| 44.9% | 44.6% | 45.2% | 44.5% | 46.6% | 47.1% | 46.9% | 46.7% | 47.8% | 44.7% | 48.7% | 48.4% | |
| 17.6% | 16.9% | 16.5% | 15.8% | 16.2% | 16.0% | 15.5% | 15.0% | 15.8% | 14.4% | 16.9% | 16.4% | |
| 53.2% | 52.6% | 53.0% | 51.7% | 51.1% | 49.0% | 50.0% | 50.0% | 50.3% | 51.5% | 54.0% | 53.4% | |
| 14.6% | 14.2% | 14.4% | 15.0% | 14.5% | 13.7% | 13.3% | 12.6% | 14.5% | 13.8% | 12.9% | 13.3% | |
| 4.9% | 3.9% | 4.6% | 5.2% | 4.1% | 2.5% | 2.8% | 2.2% | 3.7% | 3.2% | 2.7% | 3.0% | |
| 2.6% | 2.9% | 2.6% | 2.6% | 2.6% | 3.2% | 3.1% | 2.9% | 3.0% | 3.3% | 3.0% | 2.9% | |
| 31.4% | 31.7% | 32.1% | 30.7% | 31.1% | 29.9% | 31.7% | 32.6% | 30.9% | 32.5% | 35.4% | 34.6% | |
| 46.7% | 47.3% | 46.9% | 48.2% | 48.8% | 50.9% | 49.9% | 49.9% | 49.5% | 48.4% | 45.8% | 46.5% | |
| 47.3% | 48.0% | 50.0% | 50.7% | 51.2% | 54.6% | 55.0% | 55.2% | 55.7% | 53.6% | 53.5% | 55.0% | |
| 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.